What is the role of alkaline phosphatase in osteoporosis evaluation?

• A. It is specific to diagnosing osteoporosis
• B. It reflects bone turnover and helps track response to therapy with BMD
• C. It measures kidney function
• D. It predicts fracture risk alone

Answer: (B)

Alkaline phosphatase serves as a marker of bone formation and overall bone turnover. In osteoporosis management, this enzyme reflects how actively bone remodeling is occurring, which helps clinicians gauge the dynamic state of bone rather than just a static bone density snapshot. Because osteoporosis treatment aims to normalize remodeling, alkaline phosphatase is useful for tracking response to therapy when interpreted together with bone mineral density measurements. For example, therapies that suppress turnover may lower ALP levels over time, whereas agents that stimulate formation can cause a temporary rise as new bone is formed. It’s not specific to osteoporosis and can be elevated due to other bone or liver conditions, so using a bone-specific isoform provides more accurate information about bone formation. It does not measure kidney function, and it does not predict fracture risk on its own; fracture risk assessment relies on BMD plus clinical factors.